Close Menu

NEW YORK – The GenomeWeb Index rose a fraction of a percent in October, erasing part of the losses it saw in September and August.

The index underperformed the Dow Jones Industrial Average, the Nasdaq, and the Nasdaq Biotechnology Index, which gained .5 percent, nearly 4 percent, and nearly 8 percent, respectively. Individual stock performance in the GenomeWeb Index was mostly negative as 18 of the 32 stocks saw losses and 14 saw gains.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.

According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.

In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.

Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.